1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Instrument and Reagents
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Hospital Acquired Disease Testing Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Disease Testing
1.3.3 Drug-Resistance Testing
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Disease Testing Market Perspective (2018-2030)
2.2 Hospital Acquired Disease Testing Growth Trends by Region
2.2.1 Hospital Acquired Disease Testing Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Hospital Acquired Disease Testing Historic Market Size by Region (2018-2023)
2.2.3 Hospital Acquired Disease Testing Forecasted Market Size by Region (2023-2030)
2.3 Hospital Acquired Disease Testing Market Dynamics
2.3.1 Hospital Acquired Disease Testing Industry Trends
2.3.2 Hospital Acquired Disease Testing Market Drivers
2.3.3 Hospital Acquired Disease Testing Market Challenges
2.3.4 Hospital Acquired Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital Acquired Disease Testing Players by Revenue (2018-2023)
3.1.2 Global Hospital Acquired Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Disease Testing Revenue
3.4 Global Hospital Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Disease Testing Revenue in 2022
3.5 Hospital Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital Acquired Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2023-2030)
5 Hospital Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital Acquired Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Hospital Acquired Disease Testing Market Size (2018-2030)
6.2 North America Hospital Acquired Disease Testing Market Size by Country (2018-2023)
6.3 North America Hospital Acquired Disease Testing Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hospital Acquired Disease Testing Market Size (2018-2030)
7.2 Europe Hospital Acquired Disease Testing Market Size by Country (2018-2023)
7.3 Europe Hospital Acquired Disease Testing Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Disease Testing Market Size (2018-2030)
8.2 Asia-Pacific Hospital Acquired Disease Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hospital Acquired Disease Testing Market Size (2018-2030)
9.2 Latin America Hospital Acquired Disease Testing Market Size by Country (2018-2023)
9.3 Latin America Hospital Acquired Disease Testing Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Disease Testing Market Size (2018-2030)
10.2 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Life technologies
11.1.1 Life technologies Company Detail
11.1.2 Life technologies Business Overview
11.1.3 Life technologies Hospital Acquired Disease Testing Introduction
11.1.4 Life technologies Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.1.5 Life technologies Recent Development
11.2 Diatherix laboratories
11.2.1 Diatherix laboratories Company Detail
11.2.2 Diatherix laboratories Business Overview
11.2.3 Diatherix laboratories Hospital Acquired Disease Testing Introduction
11.2.4 Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.2.5 Diatherix laboratories Recent Development
11.3 Qiagen GmbH
11.3.1 Qiagen GmbH Company Detail
11.3.2 Qiagen GmbH Business Overview
11.3.3 Qiagen GmbH Hospital Acquired Disease Testing Introduction
11.3.4 Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.3.5 Qiagen GmbH Recent Development
11.4 Meridian Biosciences
11.4.1 Meridian Biosciences Company Detail
11.4.2 Meridian Biosciences Business Overview
11.4.3 Meridian Biosciences Hospital Acquired Disease Testing Introduction
11.4.4 Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.4.5 Meridian Biosciences Recent Development
11.5 Nordion
11.5.1 Nordion Company Detail
11.5.2 Nordion Business Overview
11.5.3 Nordion Hospital Acquired Disease Testing Introduction
11.5.4 Nordion Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.5.5 Nordion Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Hospital Acquired Disease Testing Introduction
11.6.4 Roche Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Cantel Medical Corporation
11.7.1 Cantel Medical Corporation Company Detail
11.7.2 Cantel Medical Corporation Business Overview
11.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Introduction
11.7.4 Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.7.5 Cantel Medical Corporation Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Detail
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Hospital Acquired Disease Testing Introduction
11.8.4 Cepheid Revenue in Hospital Acquired Disease Testing Business (2018-2023)
11.8.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
